Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Clinical Relevance of Somatic Mutations in Chronic Myelomonocytic Leukemia Undergoing Allogeneic Stem Cell Transplantation

Nico Gagelmann, Anita Badbaran, Rashit Bogdanov, PhD, Olivier Nibourel, Friedrich Stoelzel, MD, Christina Rautenberg, MD, Heiko Becker, MD, Aleksandar Radujkovic, MD, Michael Koldehoff, Prof, MD PhD, Maximilian Christopeit, PhD, Peter Dreger, Jürgen Finke, MD, Guido Kobbe, MD, Uwe Platzbecker, Marie Robin, MD, Dietrich W. Beelen, Nicolaus Kroeger, MD

Blood (2019) 134 (Supplement_1): 1713.

https://doi.org/10.1182/blood-2019-121969

Published: 2019

Journal Articles

Long-Term Survival after Transplantation in Patients with Chronic Myeloid Leukemia from HLA-Compatible Unrelated Donors: May the Stem Cell Source Influence the Outcome?

Michael Koldehoff, Prof, MD PhD, Ahmet H. Elmaagacli, Prof, MD PhD, Hellmut Dietmar Ottinger, MD PhD, Ulrich Dührsen, Prof, MD PhD, Dietrich W. Beelen

Blood (2018) 132 (Supplement 1): 5775.

https://doi.org/10.1182/blood-2018-99-118615

Published: 2018

Journal Articles

Cytomegalovirus replication reduces the relapse incidence in patients with acute myeloid leukemia

Ahmet H. Elmaagacli, Michael Koldehoff

Blood (2016) 128 (3): 456–459.

https://doi.org/10.1182/blood-2016-04-713644

Published: 2016

Journal Articles

Role Of miRNA Expression As Novel Biomarker Of GvHD After Allogeneic Stem Cell Transplantation

Michael Koldehoff, MD, Nina K Steckel, MD, Christina Maniera, Ahmet H. Elmaagacli, MD, Dietrich W. Beelen, MD, PhD

Blood (2013) 122 (21): 4585.

https://doi.org/10.1182/blood.V122.21.4585.4585

Published: 2013

Journal Articles

Reduced Relapse Risk In Patients With AML After Hhcmv-Replication Post Transplantation-First Results Of a Prospective Registration Trial

Ahmet H. Elmaagacli, MD, Nina-Kristin Steckel, MD, Meltem Kekec, Rudolf Trenschel, Markus Ditschkowski, MD, Tanja Gromke, Sandra Christoph, Hellmut Ottinger, MD, Dietrich Beelen, Michael Koldehoff, MD

Blood (2013) 122 (21): 5503.

https://doi.org/10.1182/blood.V122.21.5503.5503

Published: 2013

Journal Articles

Comparison Of Different Pretransplant Predictive Scores In Patients With Refractory Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation Including Highdose Melphalan: Results Of a Double-Center Observational Study

Nina Kristin Steckel, M.D., Markus Ditschkowski, MD, Christoph Groth, M.D., Gerda Silling, MD, U. Krug, MD, Rudolf Trenschel, MD, Hellmut Ottinger, MD, Wolfgang E Berdel, MD, Michael Koldehoff, MD, Ahmet H. Elmaagacli, Dietrich Beelen, MD, Matthias Stelljes, MD

Blood (2013) 122 (21): 4525.

https://doi.org/10.1182/blood.V122.21.4525.4525

Published: 2013

Journal Articles

Non Interventional Prospective Study On The Effect Of 48 Gene Variants On Different Endpoints After Allogeneic Stem Cell Transplantation For Patients With Acute Myeloid Leukemia

Michael Koldehoff, MD, Dietrich W. Beelen, MD, PhD, Ahmet H. Elmaagacli

Blood (2013) 122 (21): 3287.

https://doi.org/10.1182/blood.V122.21.3287.3287

Published: 2013

Journal Articles

Human Chorionic Gonadotropin Hormone Induces Indoleamine 2,3-Dioxygenase and Interleukin-10 Expression In Patients With Graft-Versus-Host-Disease

Ahmet H. Elmaagacli, MD, Markus Ditschkowski, MD, Nina-Kristin Steckel, MD, Hellmut Ottinger, MD, Uwe Hillen, MD, Rudolf Trenschel, Dietrich Beelen, MD, Michael Koldehoff, MD

Blood (2013) 122 (21): 911.

https://doi.org/10.1182/blood.V122.21.911.911

Published: 2013

Journal Articles

CMV-Replication After Allogeneic Stem Cell Transplantation Is Associated with a Gvhd-Independent Reduced Relapse Risk in Lymphoma

Ahmet H Elmaagacli, MD, PhD, Michael Koldehoff, MD, Nina K. Steckel, MD, Yael Hegerfeldt, MD, Markus Ditschkowski, Sandra Christoph, MD, Tanja Gromke, Rudof Stefan Ross, Hellmut Ottinger, Dietrich Beelen

Blood (2012) 120 (21): 1635.

https://doi.org/10.1182/blood.V120.21.1635.1635

Published: 2012

Journal Articles

Influence of Ceacams Expression in Graft-Versus-Host Disease After Allogeneic Transplantation

Michael Koldehoff, MD, Janine D. Dreesen, Ahmet H. Elmaagacli, MD, Dietrich W. Beelen, MD, Bernhard B. Singer, PhD

Blood (2012) 120 (21): 4490.

https://doi.org/10.1182/blood.V120.21.4490.4490

Published: 2012

Journal Articles

Different Panel of Gene Variants Influence Outcome of Transplant From Sibling Donors Compared to HLA-Identical Unrelated Donors

Ahmet H Elmaagacli, MD, PhD, Michael Koldehoff, MD, Nina Kristin Steckel, Markus Ditschkowski, Rudolf Trenschel, MD, Hellmut Ottinger, Dietrich W. Beelen, MD

Blood (2012) 120 (21): 4182.

https://doi.org/10.1182/blood.V120.21.4182.4182

Published: 2012

Journal Articles

Influence of Micrornas Expression in Graft-Versus-Host Disease After Allogeneic Transplantation.

Michael Koldehoff, MD, Christina Maniera, Nina Steckel, MD, Ahmet H. Elmaagacli, MD, Dietrich W. Beelen, MD

Blood (2012) 120 (21): 3062.

https://doi.org/10.1182/blood.V120.21.3062.3062

Published: 2012

Journal Articles

Response: T cells are required for the CMV-induced antileukemia effect after transplant

Ahmet H. Elmaagacli, Michael Koldehoff, Monika Lindemann, Marlene Sonius, Markus Ditschkowski, Nina Steckel, Dietrich W. Beelen

Blood (2012) 119 (4): 1090–1091.

https://doi.org/10.1182/blood-2011-11-386821

Published: 2012

Journal Articles

Inhibition of mTOR with Everolimus (RAD001) and Silencing by Vascular Endothelial Cell Growth Factor Specific siRNA Induces Additive Antitumor Activity in Multiple Myeloma Cells,

Michael Koldehoff, MD, Ahmet Elmaagacli, MD, Dietrich W. Beelen

Blood (2011) 118 (21): 3984.

https://doi.org/10.1182/blood.V118.21.3984.3984

Published: 2011

Journal Articles

Results of Simultaneously Performed Analysis of 48 Gene Variants Reported to Have Influence on Transplant outcome

Ahmet Elmaagacli, MD, Michael Koldehoff, MD, Nina Steckel, Hellmut Ottinger, Dietrich Beelen

Blood (2011) 118 (21): 3047.

https://doi.org/10.1182/blood.V118.21.3047.3047

Published: 2011

Journal Articles

Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients

Ahmet H. Elmaagacli, Nina K. Steckel, Michael Koldehoff, Yael Hegerfeldt, Rudolf Trenschel, Markus Ditschkowski, Sandra Christoph, Tanja Gromke, Lambros Kordelas, Hellmut D. Ottinger, Rudolf S. Ross, Peter A. Horn, Susanne Schnittger, Dietrich W. Beelen

Blood (2011) 118 (5): 1402–1412.

https://doi.org/10.1182/blood-2010-08-304121

Published: 2011

Journal Articles

Incidence and Outcome of Auto/Alloimmune Hepatitis with Hepatic Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation.

Michael Koldehoff, MD, Ahmet H Elmaagacli, Reinhild Klein, Dietrich Beelen

Blood (2010) 116 (21): 4534.

https://doi.org/10.1182/blood.V116.21.4534.4534

Published: 2010

Journal Articles

Additive Effects of Anti-Leukemia Capacity by Gfi-1B- and Bcr-Abl-Specific siRNA In Advanced Chronic Myeloid Leukemic Cells

Michael Koldehoff, MD, Nina Steckel, Dietrich Beelen, Ahmet Elmaagacli

Blood (2010) 116 (21): 4466.

https://doi.org/10.1182/blood.V116.21.4466.4466

Published: 2010

Journal Articles

A Cytomegalovirus Reactivation Is Associated with An Improved Progression-Free Survival Rate In Patients with Lymphoma After Allogeneic Transplant

Ahmet H Elmaagacli, Sandra Christoph, Michael Koldehoff, MD, Nina Steckel, Rudolf Trenschel, Hellmut Ottinger, Dietrich Beelen

Blood (2010) 116 (21): 4912.

https://doi.org/10.1182/blood.V116.21.4912.4912

Published: 2010

Journal Articles

Toll-Like-Receptor Expression and Cellular Immune Reconstitution In AML-Patients with Elevated Serum Ferritin Levels After Allogeneic transplant.

Ahmet Elmaagacli, Nina Steckel, Michael Koldehoff, MD, Sandra Christoph, Hellmut Ottinger, Rudolf Trenschel, Dietrich Beelen

Blood (2010) 116 (21): 1049.

https://doi.org/10.1182/blood.V116.21.1049.1049

Published: 2010

NARROW

Clinical Relevance of Somatic Mutations in Chronic Myelomonocytic Leukemia Undergoing Allogeneic Stem Cell Transplantation

Long-Term Survival after Transplantation in Patients with Chronic Myeloid Leukemia from HLA-Compatible Unrelated Donors: May the Stem Cell Source Influence the Outcome?

Cytomegalovirus replication reduces the relapse incidence in patients with acute myeloid leukemia

Role Of miRNA Expression As Novel Biomarker Of GvHD After Allogeneic Stem Cell Transplantation

Reduced Relapse Risk In Patients With AML After Hhcmv-Replication Post Transplantation-First Results Of a Prospective Registration Trial

Comparison Of Different Pretransplant Predictive Scores In Patients With Refractory Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation Including Highdose Melphalan: Results Of a Double-Center Observational Study

Non Interventional Prospective Study On The Effect Of 48 Gene Variants On Different Endpoints After Allogeneic Stem Cell Transplantation For Patients With Acute Myeloid Leukemia

Human Chorionic Gonadotropin Hormone Induces Indoleamine 2,3-Dioxygenase and Interleukin-10 Expression In Patients With Graft-Versus-Host-Disease

CMV-Replication After Allogeneic Stem Cell Transplantation Is Associated with a Gvhd-Independent Reduced Relapse Risk in Lymphoma

Influence of Ceacams Expression in Graft-Versus-Host Disease After Allogeneic Transplantation

Different Panel of Gene Variants Influence Outcome of Transplant From Sibling Donors Compared to HLA-Identical Unrelated Donors

Influence of Micrornas Expression in Graft-Versus-Host Disease After Allogeneic Transplantation.

Response: T cells are required for the CMV-induced antileukemia effect after transplant

Inhibition of mTOR with Everolimus (RAD001) and Silencing by Vascular Endothelial Cell Growth Factor Specific siRNA Induces Additive Antitumor Activity in Multiple Myeloma Cells,

Results of Simultaneously Performed Analysis of 48 Gene Variants Reported to Have Influence on Transplant outcome

Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients

Incidence and Outcome of Auto/Alloimmune Hepatitis with Hepatic Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation.

Additive Effects of Anti-Leukemia Capacity by Gfi-1B- and Bcr-Abl-Specific siRNA In Advanced Chronic Myeloid Leukemic Cells

A Cytomegalovirus Reactivation Is Associated with An Improved Progression-Free Survival Rate In Patients with Lymphoma After Allogeneic Transplant

Toll-Like-Receptor Expression and Cellular Immune Reconstitution In AML-Patients with Elevated Serum Ferritin Levels After Allogeneic transplant.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only